Healthcare of Ontario Pension Plan Trust Fund reduced its position in shares of Innospec Inc. (NASDAQ:IOSP – Free Report) by 9.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,669 shares of the specialty chemicals company’s stock after selling 6,380 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Innospec were worth $4,503,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in IOSP. EverSource Wealth Advisors LLC boosted its holdings in shares of Innospec by 1,159.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after purchasing an additional 487 shares in the last quarter. Hantz Financial Services Inc. raised its holdings in shares of Innospec by 271.0% during the 4th quarter. Hantz Financial Services Inc. now owns 575 shares of the specialty chemicals company’s stock worth $44,000 after buying an additional 420 shares in the last quarter. Danske Bank A S acquired a new position in shares of Innospec during the 3rd quarter worth $46,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of Innospec by 316.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 662 shares of the specialty chemicals company’s stock worth $51,000 after buying an additional 503 shares in the last quarter. Finally, Rockefeller Capital Management L.P. lifted its position in shares of Innospec by 125.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 728 shares of the specialty chemicals company’s stock worth $56,000 after buying an additional 405 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.
Innospec Stock Up 1.3%
NASDAQ IOSP opened at $86.07 on Friday. The company has a market cap of $2.12 billion, a price-to-earnings ratio of 18.75, a price-to-earnings-growth ratio of 2.34 and a beta of 0.93. Innospec Inc. has a twelve month low of $65.51 and a twelve month high of $92.14. The business’s fifty day moving average is $82.87 and its 200 day moving average is $79.37.
Analyst Ratings Changes
Several analysts recently weighed in on IOSP shares. Wall Street Zen raised Innospec from a “hold” rating to a “buy” rating in a research note on Saturday, July 18th. Weiss Ratings raised Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 1st. Finally, Zacks Research raised shares of Innospec from a “strong sell” rating to a “hold” rating in a report on Friday, April 24th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.
View Our Latest Stock Analysis on IOSP
Innospec Company Profile
Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
Featured Stories
- Five stocks we like better than Innospec
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
